We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+5.25%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$1.88B
AUM Growth
+$96.1M
Cap. Flow
+$21.6M
Cap. Flow %
1.15%
Top 10 Hldgs %
23.84%
Holding
447
New
26
Increased
115
Reduced
94
Closed
18

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$68.8M
2
BIIB icon
Biogen
BIIB
+$9.22M
3
MSFT icon
Microsoft
MSFT
+$8.34M
4
STZ icon
Constellation Brands
STZ
+$8.05M
5
VLO icon
Valero Energy
VLO
+$5.74M

Sector Composition

Rank Sector Weight
1 Healthcare 31.61%
2 Technology 20.98%
3 Consumer Discretionary 13.94%
4 Financials 9.85%
5 Communication Services 5.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRPT icon
1
Sarepta Therapeutics
SRPT
$1.64B
$78.6M 4.18%
533,220
+10,100
+2% +$1.23M
MSFT icon
2
Microsoft
MSFT
$3.35T
$72.9M 3.87%
543,982
-65,684
-11% -$8.34M
AMRN
3
Amarin Corp
AMRN
$298M
$51.3M 2.72%
133,525
+22,725
+21% +$8.32M
VRTX icon
4
Vertex Pharmaceuticals
VRTX
$122B
$40.1M 2.13%
221,000
+18,300
+9% +$3.2M
SBUX icon
5
Starbucks
SBUX
$121B
$37.4M 1.99%
446,950
-39,400
-8% -$3.09M
BMRN icon
6
BioMarin Pharmaceuticals
BMRN
$11.7B
$34.6M 1.84%
406,280
+54,300
+15% +$4.65M
AGIO icon
7
Agios Pharmaceuticals
AGIO
$1.95B
$34.6M 1.84%
694,700
+120,000
+21% +$6.41M
BBWI icon
8
Bath & Body Works
BBWI
$4.02B
$34.5M 1.83%
1,632,840
+259,770
+19% +$5.14M
META icon
9
Meta Platforms (Facebook)
META
$1.37T
$34.4M 1.83%
179,000
-4,000
-2% -$731K
SIMO icon
10
Silicon Motion
SIMO
$8.65B
$30.3M 1.61%
682,780
-243
-0% -$9.76K
TXRH icon
11
Texas Roadhouse
TXRH
$13.7B
$30.1M 1.6%
561,371
+20,150
+4% +$1.13M
QCOM icon
12
Qualcomm
QCOM
$160B
$30M 1.59%
394,300
-45,700
-10% -$3.35M
TIF
13
DELISTED
Tiffany & Co.
TIF
$27.7M 1.47%
295,710
+9,350
+3% +$929K
V icon
14
Visa
V
$673B
$26.8M 1.42%
156,248
+10,253
+7% +$1.68M
BMY icon
15
Bristol-Myers Squibb
BMY
$132B
$26.3M 1.4%
580,750
+529,100
+1,024% +$24.6M
TPR icon
16
Tapestry
TPR
$30.8B
$25.4M 1.35%
800,000
+150,000
+23% +$4.68M
FL
17
DELISTED
Foot Locker
FL
$25.2M 1.34%
+600,000
New +$31.2M
LKQ icon
18
LKQ Corp
LKQ
$5.76B
$25M 1.33%
940,000
SABR icon
19
Sabre
SABR
$739M
$24.4M 1.3%
1,100,000
GOOGL icon
20
Alphabet (Google) Class A
GOOGL
$4.08T
$23.5M 1.25%
436,900
+18,800
+4% +$1.09M
ON icon
21
ON Semiconductor
ON
$32.6B
$23.2M 1.23%
1,150,000
AAPL icon
22
Apple
AAPL
$4.9T
$22.3M 1.18%
446,408
+25,044
+6% +$1.22M
ADBE icon
23
Adobe
ADBE
$98.5B
$20.6M 1.1%
70,441
+5,050
+8% +$1.4M
CELG
24
DELISTED
Celgene Corp
CELG
$19.7M 1.05%
213,100
-724,000
-77% -$68.8M
GILD icon
25
Gilead Sciences
GILD
$163B
$18.9M 1%
281,940
-18,500
-6% -$1.22M

Similar funds

Erste Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Erste Asset Management held 447 positions worth $1.88B, up 5.4% from $1.79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Erste Asset Management's Q2 2019 filing shows 26 new, 115 increased, 94 reduced and 18 closed positions. Its largest new stake was Foot Locker: 600,000 shares worth $25.2M. The largest sale was Celgene Corp, an estimated $68.8M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Erste Asset Management's largest Q2 2019 buy was Foot Locker: 600,000 shares worth $25.2M.
  • Erste Asset Management added most to Bristol-Myers Squibb in Q2 2019, an estimated $24.6M increase.
  • Erste Asset Management's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $68.8M.
  • Erste Asset Management fully exited Scotiabank in Q2 2019, selling an estimated $1.55M.
  • Erste Asset Management's ten largest holdings make up 24% of its $1.88B portfolio in Q2 2019.
  • Erste Asset Management opened 26 new positions and closed 18 in Q2 2019.
  • Erste Asset Management's portfolio value rose 5.4% quarter-over-quarter to $1.88B.

Based on Erste Asset Management's 13F filing for Q2 2019, filed 22 Nov 2024.